Our study revealed that high expression of TAS2R10, TAS2R3, and TAS2R50 is significantly associated with poor prognosis in ovarian cancer, as demonstrated by our analysis of clinical samples (Figure 5D). The gene discussed is TAS2R10; the disease is ovarian carcinoma.